Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancerHisatsugu Goto, Yasuhiko Nishioka, Fumitaka Ogushi et al.|Respiratory Investigation|2017Cited by 13
Phase II study of S-1 with patient-reported outcome evaluation in elderly patients with previously untreated advanced non-small cell lung cancerHirokazu Ogino, Yasuhiko Nishioka, Hisatsugu Goto et al.|Lung Cancer|2017Cited by 0